Phase 2 Study of Aspirin Plus Exemestane Comparing With Exemestane Alone in the Adjuvant Treatment of Postmenopausal Breast Cancer
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Quality of Life
Peng Yuan, M.D.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
China: Ethics Committee